Sincerity Applied Materials (SINC) 10-Q 14 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 11, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'SYMBID CORP.	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Entity Central Index Key	'0001532595	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	31,663,100
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Condensed_Balance_Sheets

Condensed Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets	'	'
Cash	$500,050	$891,592
Accounts receivable, less allowance for doubtful accounts of $16,315 and $10,718 respectively	31,639	2,897
Value added tax receivable	107,391	40,232
Prepaid expenses and other current assets	52,536	19,254
Total current assets	691,616	953,975
Property and equipment - at cost, less accumulated depreciation and amortization	5,791	4,259
Investments in associated companies	11,218	1,432
Intangible assets, net	1,117,563	0
Total Assets	1,826,188	959,666
Current Liabilities	'	'
Accounts payable	268,729	138,495
Accrued expenses and other current liabilities	254,681	256,928
Deferred government grants	'	11,017
Current maturities of notes payable	132,892	41,657
Total current liabilities	656,302	448,097
Notes payable, less current maturities	105,515	237,973
Derivative liability - warrants	407,052	303,662
Total Liabilities	1,168,869	989,732
STOCKHOLDERS' DEFICIT	'	'
Preferred stock Authorized: $0.001 par value,10,000,000 shares authorized Issued and outstanding: nil preferred shares	0	0
Common stock Authorized: $0.001 par value, 290,000,000 shares authorized Issued and outstanding: 31,573,100 and 34,268,736 respectively	31,573	34,268
Additional paid-in capital	4,473,550	2,041,052
Accumulated other comprehensive loss	-135,069	-44,029
Accumulated deficit	-3,629,826	-2,001,760
Total Symbid Corp. stockholders' equity	740,228	29,531
Noncontrolling interests	-82,909	-59,597
Total stockholders' equity (deficit)	657,319	-30,066
Total liabilities and stockholders' equity (deficit)	$1,826,188	$959,666

Condensed_Balance_Sheets_Paren

Condensed Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Assets [Abstract]	'	'
Allowance for doubtful accounts	$8,436	$10,718
Preferred Stock, par value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	290,000,000	290,000,000
Common Stock, shares issued	31,573,100	34,268,736
Common Stock, shares outstanding	31,573,100	34,268,736

Condensed_Statements_of_Operat

Condensed Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Revenues	'	'	'	'
Crowdfunding	$50,889	$22,979	$201,034	$53,387
Other	1,990	6,385	10,040	8,137
Total revenues	52,879	29,364	211,074	61,524
Operating Expenses	'	'	'	'
Selling, general and administrative	456,689	124,983	1,037,469	300,133
Professional fees	234,981	269,170	638,560	294,517
Research and development costs	111,693	11,223	256,441	36,335
Depreciation and amortization	29,409	325	30,077	975
Total Operating Expenses	832,772	405,701	1,962,547	631,960
Operating loss	-779,893	-376,337	-1,751,473	-570,436
Other Income (Expense)	'	'	'	'
Fair value adjustment derivative liability - warrants	75,972	0	160,985	0
Interest expense	-3,568	-5,498	-11,387	-16,176
Government subsidy	0	8,000	10,963	23,999
Equity in losses of Gambitious B.V. and Kredietpaspoort	-38,481	-13,570	-47,225	-48,501
Other income and expense	-4,050	0	-20,183	0
Total other income (expense)	29,873	-11,068	93,153	-40,678
Net Loss	-750,020	-387,405	-1,658,320	-611,114
Net loss attributable to non-controlling interests	-14,631	-8,071	-30,254	-27,401
Net loss attributable to Symbid Corp. shareholders	($735,389)	($379,334)	($1,628,066)	($583,713)
Basic and diluted loss per common share	($0.02)	($0.02)	($0.06)	($0.03)
Weighted average number of shares outstanding	'	'	'	'
Basic and diluted	30,741,624	22,692,867	27,175,652	22,104,541

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Consolidated Statements Of Comprehensive Loss	'	'	'	'
Net loss	($750,020)	($387,405)	($1,658,320)	($611,114)
Other comprehensive loss: Foreign currency translation adjustments	-81,739	-5,019	-91,040	2,023
Comprehensive loss	-831,759	-392,424	-1,749,360	-609,091
Net loss attributable to non-controlling interests	-14,631	-8,071	-30,254	-27,401
Foreign currency translation income attributable to non-controlling interests	5,859	-1,328	6,942	-983
Comprehensive loss attributable to non-controlling interests	-8,772	-9,399	-23,312	-28,384
Comprehensive loss attributable to Symbid Corp. shareholders	($822,987)	($383,025)	($1,726,048)	($580,707)

Condensed_Statements_of_Cash_F

Condensed Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flow from operating activities:	'	'
Net Loss	($1,658,320)	($611,114)
Adjustments to reconcile net loss to net cash used by operating activities:	'	'
Stock based compensation to non-employees	231,833	0
Depreciation and amortization	30,077	975
Losses recorded from investment in Gambitious B.V.	47,225	48,501
Fair value adjustment derivative liability - warrants	-160,985	0
Deferred government grants	-10,963	-23,995
Provision for doubtful accounts	-1,538	0
Changes in operating assets and liabilities:	'	'
Accounts receivables	-29,433	-14,752
Prepaid expenses and other current assets	-112,380	24,676
Accounts payable	150,882	26,224
Accrued expenses and other current liabilities	-98,652	162,003
Net Cash Used In Operating Activities	-1,612,254	-387,482
Cash flows from investing activities	'	'
Investment in associated companies	-57,306	-1,387
Acquisition of property and equipment	-3,248	0
Net cash used in investing activities	-60,554	-1,387
Cash flows from financing activities	'	'
Proceeds from line of credit	0	29,555
Proceeds from the issuance of common stock, net of issuance costs	1,369,647	378,223
Repayments of notes payable	-20,639	-20,133
Net Cash Provided By Financing Activities	1,349,008	387,645
Effect of exchange rate changes on cash	-67,742	9,216
Net (decrease) / increase in cash	-391,542	7,992
Cash and cash equivalents, beginning of year	891,592	7,732
Cash and cash equivalents, end of year	500,050	15,724
Supplemental cash flow disclosures	'	'
Interest paid	11,387	16,176
Non-cash investing	'	'
Fair value of shares issued related to asset acquisition	1,195,092	0
Conversion of notes payable	$0	$85,681

1_BUSINESS_ORGANIZATION_AND_LI

1. BUSINESS, ORGANIZATION AND LIQUIDITY	9 Months Ended
	Sep. 30, 2014
Nature of Operations and Continuance of Business	'
1. BUSINESS, ORGANIZATION AND LIQUIDITY	'
	Interim Condensed Consolidated Financial Statements
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conformity with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures included in these financial statements are adequate to make the information presented not misleading. The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual consolidated financial statements, and in our opinion reflect all adjustments, which include normal recurring adjustments necessary for a fair presentation in accordance with GAAP and SEC regulations for interim financial statements. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that we will have for any subsequent period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes to those statements for the year ended December 31, 2013 included in our Annual Report on Form 10-K.
	Business and Organization
	Symbid Corp. was incorporated as HapyKidz.com, Inc. in the state of Nevada on July 29, 2011. On September 4, 2013, we filed a Certificate of Amendment to our Articles of Incorporation with the Nevada Secretary of State to change our name from HapyKidz.com, Inc. to Symbid Corp, which we believe more accurately reflects our current business. The Company continues to be a “smaller reporting company,” as defined under the Exchange Act.
	Symbid Holding B.V. (“Symbid Holding”) was incorporated on October 3, 2013 organized under the laws of the Netherlands.  Symbid Holding was organized to serve as the holding company for all of Symbid’s business activities in the Netherlands and in other countries.  As such, on October 3, 2013, the holders of the capital shares of Symbid B.V. exchanged their shares for capital shares of Symbid Holding and, as a result, Symbid B.V. became a wholly owned subsidiary of Symbid Holding. Symbid B.V. is now the operating entity for the Company’s business in the Netherlands.
	On December 6, 2013, the Company closed a Share Exchange pursuant to which the 19 shareholders of Symbid Holding B.V. sold all of their capital stock in Symbid Holding B.V. to us in exchange for 21,170,000 shares of our common stock, $0.001 par value per share. Because the Company had no operations at the time of our acquisition of Symbid Holding, Symbid Holding is considered to be the predecessor Company for financial reporting purposes.
	The Share Exchange has been accounted for as a “reverse acquisition,” and Symbid Holding is deemed to be the acquirer in the reverse acquisition. Consequently, the assets and liabilities and the historical operations that are reflected in the financial statements prior to the Share Exchange are those of Symbid Holding and are recorded at the historical cost basis of Symbid Holding. The condensed consolidated financial statements after completion of the Share Exchange include the assets and liabilities of Symbid Holding, historical operations of Symbid Holding and operations of the Company and its subsidiaries from the Closing Date of the Share Exchange. As a result of the issuance of the shares of our common stock pursuant to the Share Exchange, a change in control occurred as of the date of consummation of the Share Exchange.
	The main operating entity of Symbid Corp. is Symbid B.V. (“Symbid B.V.”) and was incorporated in Utrecht, Netherlands on March 29, 2011 under the laws of the Netherlands. The Company was launched in April 2011 in its headquarters in Rotterdam, The Netherlands as one of the first three equity based crowd funding forerunners worldwide. Entrepreneurs use Symbid to obtain business growth funding from the crowd in exchange for a part of the equity of their company. Investors can participate for as little as $25.50, and become shareholders of start-up companies or growing businesses in need of capital.
	Since August 2012, the Company is one of the first platforms worldwide to offer multiple models of crowd funding on a progressive scale for Small and Medium Enterprises (SME’s), integrating a unique legal structure into the IT-infrastructure of the crowd funding platform. The goal of the Company is to create a portfolio of crowd funding products, where anyone interested in crowd funding can find their right solution.
	The Symbid infrastructure serves as a matchmaking platform, with added value for both entrepreneurs and investors on a global scale. The Company earns success fees and transaction fees charged to the entrepreneurs and investors active on the platform. In addition to matchmaking on the Company platform, the Company licenses its infrastructure in several forms to other partners.
	As of September 30, 2014, the Company, through its ownership in Gambitious Coöperatie UA (“Gambitious Coop”) has a 12% ownership interest in Gambitious B.V. (“Gambitious”), a company located in the Netherlands, which uses the Company’s platform to raise capital for video games produced by a wide range of developers.
	As of September 30, 2014, the Company has a 12.53% ownership in Kredietpaspoort U.A. (“Kredietpaspoort”), a Cooperative located in the Netherlands, through its wholly owned subsidiary Symbid B.V. and Symbid Coop, a variable interest entity which we effectively control through corporate governance rather than through any ownership further discussed in Note 4. The Kredietpaspoort is a cloud- based platform that is in development to provide credit evaluation and financing options to SME companies in the Netherlands. In addition, the Company’s Chief Executive Officer and Chief Commercial Officer each own 5.15% and 4.96%, respectively, of Kredietpaspoort an investment of the Company further discussed in Note 4. The combined holdings in Kredietpaspoort by Symbid B.V., Symbid Coop, and our executive officers totals approximately 22.64%.
	As of September 30, 2014, the Company currently has a 7% ownership in Equidam Holding B.V. (“Equidam”). Equidam started as an online valuation tool for private companies with a particular focus on SME’s, Equidam now also offers monitoring services to investors on the Company’s platform.
	Liquidity and Going Concern Matters
	The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles, which contemplates continuation of the Company as a going concern.
	The Company has suffered recurring losses with a net loss during the twelve months ended December 31, 2013 of $1,260,196 and net losses for the three and nine month periods ended September 30, 2014 of approximately $750,000 and $1,658,000. At September 30, 2014 and December 31, 2013, the Company had working capital of $35,000 and $506,000, respectively. As of September 30, 2014, the Company had cash on hand of approximately $500,000 and current liabilities to credit institutions of $133,000. The recurring losses raise substantial doubt about the Company’s ability to continue as a going concern. The recoverability of a major portion of the recorded asset amounts shown in the accompanying condensed consolidated balance sheet is dependent upon continued operations of the Company, which in turn, is dependent upon the Company’s ability to raise capital and/or generate positive cash flows from operations. The financial statements do not include any adjustments related to the recoverability and classification of recorded assets and classifications that might be necessary in the event the Company cannot continue in existence.

2_SUMMARY_OF_SIGNIFICANT_ACCOU

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2014
Summary of Significant Accounting Policies	'
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Principles of Consolidation
	The accompanying condensed consolidated financial statements include the accounts of the Company and its significant subsidiaries on a consolidated basis. The Company also includes subsidiaries over which a direct or indirect legal or effective control exists and for which the Company is deemed to direct the significant activities and has the obligation to absorb the losses or benefits of the entities. Intercompany balances and transactions with other consolidated entities have been eliminated. The condensed consolidated financial statements have been prepared in accordance with U.S. GAAP, and include the Company’s accounts as well as those of Symbid Coöperatie UA (“Symbid Coop”) a certain variable interest entity (“VIE”) for which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Noncontrolling Interests
	The Company presents noncontrolling interests as a component of equity. Changes in a parent’s ownership interest while the parent retains its controlling interest will be accounted for as equity transactions, and upon loss of control, retained ownership interest will be re-measured at fair value, with any gain or loss recognized in earnings. Income and losses attributable to the noncontrolling interest associated with Symbid Coop are presented separately in the Company’s condensed consolidated statement of operations.
	Revenue Recognition
	The Company generates its revenue from administration and success fees of transactions on the crowd funding platform. Revenue from administration fees is collected and recognized at the moment an investor subscribes on the platform. Revenue from success fees are recognized at the time the crowdfunding proposition is successfully funded and there are no further obligations to the customer. There is no credit risk since the fees are collected directly at the moment that the transaction takes place on the platform. There is no right of return to investors once a crowdfunding proposition has been successfully funded. Other revenue is generated by licensing the platform to third parties. Revenue is accounted for on a monthly basis for the agreed monthly licensed fee. There is limited credit risk. If the monthly license fee is not paid, the Company is entitled to set the platform offline.
	Share Based Compensation
	ASC Topic 718, Compensation – Stock Compensation, requires that compensation expense for employee stock- based compensation be recognized over the requisite service period based on the fair value of the award on the date of grant.
	The Company accounts for the granting of equity based awards to employees using the fair value method, whereby all awards to employees will be recorded at fair value on the date of grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. The fair value of equity based awards is estimated using the most recent securities offering of the same or similar share classes. Compensation costs for stock- based payments to employees with graded vesting are recognized on a straight line basis.
	Based on guidance in ASC 505, Equity share based payments to non- employees are measured at the fair value of the consideration received or the fair value of the equity instruments issued or liabilities incurred, whichever is more reliably measurable. The fair value of share based payments to non- employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for share based payments with graded vesting are recognized on a straight- line basis. The cost of the share based payments to non- employees that are fully vested and non- forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.
	Derivative Liability - Warrants
	In connection with the private placement offering (“PPO”) on December 6, 2013, the Company issued warrants to purchase shares of its common stock to investors who purchased units in the PPO (“Investor Warrants”). The Company also issued warrants to purchase shares of its common stock to brokers in connection with the PPO (“Broker Warrants”). Both the Investor and Broker Warrants, at the option of the holder, may be exercised by cash payment of the exercise price to the Company. The warrants may be exercised on a cashless basis in accordance with the warrant agreement commencing one year after the initial closing date of the PPO if no registration statement registering the shares underlying the warrants is then in effect. Further, the exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including stock splits, stock dividends, and future issuances of the Company’s equity securities. As a result, the fair value of these warrants were classified as liabilities under the provisions of FASB ASC Topic 815-40, Contracts in an Entity’s Own Equity, as they are not indexed to the Company’s own stock. The fair value of these warrants was estimated using a Monte Carlo simulation. The Company updates its estimate of the fair value of the warrant liabilities in each reporting period as new information becomes available and any gains or losses resulting from the changes in fair value from period to period are included as other income or expense. The Company thus uses model-derived valuations where inputs are observable in active markets to determine the fair value and accordingly classify such warrants in Level 3 per ASC 820, Fair Value Measurements.
	Fair Value of Financial Instruments
	The accounting standard for fair value establishes a framework for measuring fair value and enhances fair value measurement disclosure. Under the provisions of the pronouncement, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.
	GAAP establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is described below:
	Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
	Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
	Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
	The Company’s current financial assets and liabilities approximate fair value due to their short term nature and include cash accounts. The Company’s borrowings approximate fair value as the rates of interest are similar to what they would receive from other financial institutions. Refer to Note 9 on derivative liability- warrants, which have been classified as Level 3 instruments.
	Concentrations of Credit Risk
	Cash Held in Banks
	The Company has cash balances at financial institutions located in the Netherlands. Balances at financial institutions in the Netherlands may, from time to time, exceed insured limits. Currently the insured limit amounts to approximately $127,000.
	Accounts Receivable
	Customer accounts typically are collected within a short period of time, and based on its assessment of current conditions and its experience collecting such receivables, management believes it has no significant risk related to its concentration within its accounts receivable.
	Foreign Currency Translation
	The Company uses the United States dollar (“U.S. dollars” or “USD”) for financial reporting purposes.  The Company's subsidiaries maintain their books and records in their functional currency, the Euro (“EUR”), the currency of the Netherlands.
	In general, for consolidation purposes, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of operations and cash flows are translated at average exchange rates during the reporting period.  As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet.  Equity accounts are translated at historical rates.  Adjustments resulting from the translation of the financial statements are recorded as accumulated other comprehensive income, or loss.
	Property and Equipment
	Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization is charged to operations using the straight-line method over the estimated useful lives of 5 years. Property and equipment consists mainly of computers.
	Expenditures for maintenance and repairs are charged to operations as incurred. Expenditures for betterments and major renewals are capitalized. The cost of assets sold or retired and the related amounts of accumulated depreciation are eliminated from the accounts in the period of disposal, and any resulting gains or losses are included in operations.
	Income Taxes
	Income taxes have been determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes result from differences between the financial statement and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment.
	Net Loss Per Common Share
	Basic and diluted net loss per share is presented in conformity with ASC Topic 260, Earnings per Share, for all periods presented. In accordance with this guidance, basic and diluted net loss per share was determined by dividing net loss applicable to common stockholders by the weighted- average common shares outstanding during the period. In a period where there is a net loss position, diluted weighted average shares are the same as basic weighted average shares. Shares used in the diluted net loss per common share calculation exclude potentially dilutive share equivalents, as the effect would be antidilutive.
	Risks and Uncertainties
	The Company’s operations are subject to a number of risks, including but not limited to, changes in the general economy, demand for the Company’s platform, the success of its customers, research and development results, uncertainties surrounding crowd funding rules and regulations, and the ability to attract new funding.
	Accounts Receivable
	Accounts receivable are carried at the amount billed to a customer, net of the allowance for doubtful accounts, which is an estimate for credit losses based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received. The Company reviews the collectability of accounts receivable based on an assessment of historical experience, current economic conditions, and other collection indicators. At September 30, 2014 and December 31, 2013, the Company has recorded an allowance for doubtful accounts for $8,436 and $10,718, respectively.
	Comprehensive Loss
	Comprehensive loss refers to revenues, expenses, gains and losses that under U.S. GAAP are included in comprehensive loss but are excluded from net loss as these amounts are recorded directly as an adjustment to stockholders’ equity. The Company’s other comprehensive loss is comprised of foreign currency translation adjustments.
	Cost Method Investments
	Direct and or indirect investments in business entities in which the Company does not have a controlling financial interest and has no ability to exercise significant influence over operating and financial policies (generally 0-20 percent ownership) are accounted for by the cost method.
	Equity Method Investments
	Direct and/or indirect investments in business entities in which Symbid Corp. does not have a controlling financial interest, but has the ability to exercise significant influence or operating and financial policies (generally 20-50 percent ownership) are accounted for by the equity method.
	Intangible Assets with Definite Lives
	An intangible asset arose as the result of the acquisition of the FAC B.V., a limited liability entity incorporated in the Netherlands, resulting in the acquisition of a perpetual, worldwide, exclusive license to a software library of infrastructure technology. The Company amortizes the costs of the acquired intangible asset using the straight- line method over the estimated useful life of 7 years.
	The carrying value of the intangible asset with a definite live is reviewed on a regular basis for the existence of facts or circumstances that the intangible asset may be impaired. An asset is considered impaired when the undiscounted future cash flows expected to result from its planned use are less than the carrying value. If the carrying value of an asset is deemed not recoverable, it is adjusted downward to its estimated fair value.
	Recent Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, "Revenue from Contracts with Customers: (Topic 606)." This ASU affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605, "Revenue Recognition," and most industry-specific guidance. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance also includes a cohesive set of disclosure requirements that will provide users of financial statements with comprehensive information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from a reporting organization’s contracts with customers. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated condensed financial statements.

3_VARIABLE_INTEREST_ENTITY_SYM

3. VARIABLE INTEREST ENTITY- SYMBID COOP	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
3. VARIABLE INTEREST ENTITY- SYMBID COOP	'
	The Company holds a variable interest in Symbid Coop. Symbid Coop is the lessee of the Company’s online crowd funding platform. Symbid B.V. licenses the online platform exclusively to Symbid Coop. The management of Symbid Coop is the same as the management of Symbid B.V. and Symbid Holding.
	The Company has an implicit variable interest in Symbid Coop through common control and management has the ability to compel payment whether stated or silent in the lease agreement. The Company is deemed to be the primary beneficiary of Symbid Coop and has a controlling financial interest as it has the power to direct the activities of the VIE that most significantly impact Symbid Coop’s economic performance.
	The Company reassesses every reporting period the presentation of Symbid Coop to conclude if consolidation is required. As such, the conclusion regarding the primary beneficiary status is subject to change and circumstances are continually reevaluated.
	The classification and carrying amounts of assets and liabilities of Symbid Coop in the condensed consolidated balance sheet are as follows:
		30-Sep-14		31-Dec-13
	Current assets	$	104,552	$	53,414
	Current liabilities	$	187,463	$	113,137
	The assets related to Symbid Coop are not restricted.

4_INVESTMENT_IN_ASSOCIATED_COM

4. INVESTMENT IN ASSOCIATED COMPANIES	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
4. INVESTMENT IN ASSOCIATED COMPANIES	'
	GAMBITIOUS
	In February 2014, the Company sold 912 memberships in Gambitious Coop. As a result of this transaction, the Company’s direct interest in Gambitious Coop decreased from 63% to 46% and the Company no longer has a controlling interest. Accordingly, Symbid has derecognized the assets, liabilities and equity components related to Gambitious Coop and recognized a loss in other income and expense of  $1,631 for the nine months ended September 30, 2014, as a result of the loss in control and resulting deconsolidation. The derecognition of Gambitious Coop did not have a material impact on the condensed consolidated financial statements of the Company.
	In April 2014, the Company participated in a funding round of Gambitious and contributed capital of approximately $25,000.
	In May 2014, the Company sold 193 memberships in Gambitious Coop. As a result of this transaction, the Company has a direct interest in Gambitious Coop of 42%. As of September 30, 2014 the Company remains an indirect shareholder in Gambitious B.V. for 12% of total shares issued. The Company accounts for its investment in Gambitious Coop on the equity method basis of accounting.
	KREDIETPASPOORT
	As of April 2014, Symbid B.V. and Symbid Coop acquired membership interests of 6.50% and 6.03% of Kredietpaspoort, respectively. The initial investments in Kredietpaspoort by Symbid B.V. and Symbid Coop of approximately $17,000 and $16,000, respectively, are recorded in Investments in Associated Companies. In addition, our Chief Executive Officer and Chief Commercial Officer, both of whom are Directors of the Company, each acquired membership interests of 5.15% and 4.96%, respectively, in Kredietpaspoort. The Company is accounting for its investment in Kredietpaspoort on the equity method basis of accounting, as Symbid has the ability to exercise significant influence over the operating and financial policies of Kredietpaspoort through representation on the Kredietpaspoort board of directors and the combined voting interest of Symbid and its Executive Officers. With the exception of the investment by Symbid B.V. and Symbid Coop in April 2014, there have been no material transactions with Kredietpaspoort during the reporting period.
	EQUIDAM
	As of August 2013, the Company acquired a 10% interest in Equidam for an amount of $1,400 recorded in Investments in Associated Companies. As September 30, 2014, the Company currently has a 7% ownership in Equidam, as the initial investment was diluted through a subsequent round of seed funding. The Company is accounting for their investment in Equidam on the cost basis of accounting. There have been no material transactions with Equidam during the reporting period.

5_ACQUISITION

5. ACQUISITION	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
5. ACQUISITION	'
	On July 29, 2014, our wholly owned subsidiary Symbid Holding, a limited liability Corporation in the Netherlands, acquired all the issued and outstanding shares of FAC B.V. in exchange for 2,750,000 shares of our restricted common stock. The sole asset of the FAC B.V. was a perpetual, worldwide, exclusive license to a software library of infrastructure technology, upon which we intend to develop a platform to enable cloud based financing solutions for small and medium sized enterprises, expanding on our current equity based crowdfunding solutions in the Netherlands. The asset assumed in the acquisition of the FAC B.V. does not meet the definition of a business and, therefore, has been accounted for as an asset acquisition.
	The Company measured the fair value of the restricted shares issued as consideration in the acquisition of the FAC B.V. based on a weighted average fair value calculation using available observable inputs of recent arm’s length transactions in the Company’s recent private placement offering and, to a lesser extent, the publicly traded share price, resulting in a fair value of approximately $1,195,000. The total purchase price was allocated to the software library acquired in the acquisition. Transaction costs directly related to the acquisition of the software of approximately $17,000 incurred to acquire the software have been capitalized. The software was deemed to have a useful life of 7 years.

6_INTANGIBLE_ASSETS

6. INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
6. INTANGIBLE ASSETS	'
	Intangible assets consist solely of software obtained through the acquisition of the FAC B.V. As of September 30, 2014, software had carrying value of  $1,117,563, net of accumulated amortization of $27,258. There were no intangible assets at December 31, 2013. During the three and nine month period ending September 30, 2014, amortization expense related to the software totaled $27,258.
	Estimated future amortization expense is approximately $41,000 for 2014 and approximately $164,000 annually through 2021.

7_NOTES_PAYABLE

7. NOTES PAYABLE	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
7. NOTES PAYABLE	'
			30-Sep-14			31-Dec-13
	Working capital facility		$	153,484		$	187,371
	Subordinated loan – related party			84,926			92,259
	Total notes payable		$	238,410			279,630
	Less - Current Maturities			-132,895	)		(41,657	)
	Notes payable, less current maturities			105,515		$	237,973
	Working Capital Facility
	The Company has two credit facilities with the Rabobank, a national bank in the Netherlands.
	The facility consists of the following two agreements:
	1.	Long term loan for approximately $240,000, bears interest of approximately 6.4%, principal and interest payable quarterly. The loan decreases on a quarterly basis by approximately $10,000, starting on September 30, 2012. As of September 30, 2014, the loan balance was $153,484.
	2.	A line of credit of approximately $80,000 with a floating interest rate of approximately 4.5% at December 31, 2013. The balance on the credit facility at September 30, 2014 was $0.
	The working capital facility is secured by the following assets:
	1.	Assets of the Company including receivables and intellectual property developed by the Company.
	2.	Guarantee by principal members of management up to approximately $60,000.
	3.	Guarantee by the Netherlands government for the remaining balance in a hypothetical liquidation.
	Note Payable - Related Party
	The Company issued two notes with an interest rate of 4% to a stockholder of the Company during 2012 for approximately $79,000 and $8,000. On March 1, 2013 the notes and accrued interest were converted into 736,450 shares of common stock valued at $85,681.
	Subordinated Loan - Related Party
	A stockholder of the Company has granted a loan of approximately $85,000 to the Company due on September 15, 2015 with interest only payments of 4% per annum. The loan is subordinate to the interests of the working capital facility and is unsecured.
	Aggregate Maturity Schedule of Borrowings
	The aggregate maturities of notes payable outstanding are approximately as follows:
	THE TWELVE MONTHS ENDING September 30,
	2015		$	132,894
	2016			38,375
	2017			38,375
	2018			28,766
			$	238,410

8_CAPITAL_STOCK

8. CAPITAL STOCK	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
8. CAPITAL STOCK	'
	Concurrent with the closing of the Share Exchange in December 2013, the Company completed a closing of the PPO in which 3,089,736 units of our common stock and warrants were sold at a price of $0.50 per unit for a total consideration of $1,549,368. During the initial closing of our PPO, the Company incurred advisory and professional fees of $406,035, of which issuance costs of $60,250 were allocated to equity issuance costs and deducted from additional paid in capital.
	On February 5, 2014, a second closing of the private placement offering was completed in which an additional 373,984 units were sold which generated gross proceeds of $186,987. In connection with the second closing, we incurred advisory and professional fees of $80,251, of which issuance costs of  $7,750 were allocated to equity issuance costs and deducted from additional paid in capital.
	On May 20, 2014, a third and final closing of the private placement offering was completed in which an additional 2,380,810 units were sold generating gross proceeds of $1,190,405. In connection with the third closing, we incurred advisory and professional fees of $81,724, none of which were allocated to equity issuance costs and deducted from additional paid- in capital.
	The following table displays the allocation of proceeds in connection with the PPO through September 30, 2014:
	Gross proceeds from the PPO	$	2,926,760
	Issuance costs		(68,000	)
	Proceeds allocated to warranty liability		(570,268	)
	Proceeds allocated to common stock	$	2,288,492
	Each of the units sold in the PPO consisted of one share of common stock and a warrant to purchase one share of common stock. The warrants are exercisable for a period of three years at a purchase price of $0.75 per share. As of September 30, 2014, the Company has issued 93,000 warrants to the placement agent as a commission. These warrants are exercisable for a period of three years at a purchase price of $0.50 (see Note 9).
	Net Loss Per Share
	Basic and diluted net loss per share is presented in conformity with ASC Topic 260, Earnings per Share, for all periods presented. In accordance with this guidance, basic and diluted net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted-average common shares outstanding during the period. In a period where there is a net loss position, diluted weighted-average shares are the same as basic weighted-average shares. Shares used in the diluted net loss per common share calculation exclude potentially dilutive share equivalents as the effect would be antidilutive. As of September 30, 2014 there are 5,853,530 Investor and 93,000 Broker Warrants which are excluded on the aforementioned basis.
	In connection with the Share Exchange described in Note 1, 9,170,000 shares of the Company’s common stock was held in escrow for the potential acquisitions of Gambitious and Equidam (“Acquisition Escrow Shares”) and an additional 600,000 shares was placed in escrow to secure the indemnification obligations of the shareholders of the Company. Of the 9,170,000 shares held in escrow, 5,000,000 and 3,000,000 of the Acquisition Escrow Shares were assigned to the potential acquisitions of Gambitious and Equidam, respectively. The remaining 1,170,000 shares in escrow are in recognition of the pre- Share Exchange shareholders ownership interests in Gambitious of 18%, resulting in 900,000 shares, and Equidam of 9%, resulting in 270,000 shares, which are to be distributed on a pro- rata basis to the pre- Share Exchange shareholders of the Company upon the earlier of (i) the closings of the respective acquisitions of Gambitious or Equidam or (ii) six months following the close of the Share Exchange on June 6, 2014.
	On June 6, 2014, the Company determined not to proceed with the purchase of the additional shares in Gambitious, resulting in the cancellation of the 5,000,000 shares of common stock held in escrow.  An additional 300,000 shares were cancelled from the 900,000 shares due to the pre- Share Exchange shareholders as a result of subsequent sales of membership interests in Gambitious BV in February 2014 and May 2014 described in Note 4, which reduced the Company’s indirect ownership interest in Gambitious from 18% to 12%.
	On September 2, 2014, the Company determined not to proceed with the purchase of the additional shares in Equidam, resulting in the cancellation of the 3,000,000 shares of common stock held in escrow.
	2013 Equity Incentive Plan
	Before the Share Exchange on December 6, 2013, the Board of Directors adopted and the stockholders approved, the 2013 Equity Incentive Plan (the “2013 Plan”), which provides for the issuance of incentive awards of up to 5,000,000 shares of common stock to officers, key employees, consultants and directors. On July 24, 2014 the Company issued an aggregate of 1,003,500 restricted stock units to certain employee and non- employees under the 2013 Equity Incentive Plan..Refer to Note 11 on share based payments.
	Common and Preferred Stock
	The Company’s Certificate of Incorporation authorizes the issuance of 300,000,000 shares of capital stock, consisting of 290,000,000 shares of Common Stock and 10,000,000 shares of “blank check” preferred stock, $0.001 par value per share.
	Private investment
	The Company issued 3,198,414 shares of common stock valued at $378,223 for cash during the twelve months ended December 31, 2013. In addition the Company issued 3,098,736 shares of common stock in an initial closing of the PPO at December 6, 2013. In a second and third closing of the PPO, the Company issued 373,984 and 2,380,810 shares of common stock, respectively. Total funding through the PPO has amounted to $2,926,760, of which $68,000 was paid to placement agents and other parties related to issuance costs through the closing of the PPO. Of the $2,926,760 a fair value of $570,268 was attributed to the warrants issued with the common stock (see Note 9).
	Stock issued for convertible notes payable
	On March 1, 2013 the Company issued 736,450 shares of common stock valued at $85,681 in connection with the conversion of notes payable and accrued interest (see Note 7).
	Noncontrolling Interests
	The composition of the net loss attributable to noncontrolling interests is as follows:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Symbid Coop- 100%	$	(14,631	)	$	-2,840		$	(29,652	)	$	(9,455	)
	Gambitious Coop- 37%		-			(5,231	)		-602			(17,946	)
	Total	$	(14,631	)	$	(8,071	)	$	(30,254	)	$	(27,401	)
	Prior to the loss of control in Gambitious Coop in February 2014, the Company held a noncontrolling interest of 37%.

9_DERIVATIVE_LIABILITY_WARRANT

9. DERIVATIVE LIABILITY - WARRANTS	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
9. DERIVATIVE LIABILITY - WARRANTS	'
	The fair value of 5,853,530 investor and 93,000 broker warrants issued, under which an aggregate of the 5,946,530 shares of the Company’s common stock may be purchased in connection with the PPO, totaled $570,268, of which $558,996 related to Investor Warrants and $11,272 related to Broker Warrants.
	The Company uses a Monte Carlo simulation to estimate the fair value of the warrants. In order to estimate the fair value of the anti-dilution feature, the Company estimated the potential impact of future financing needs on the warrants. A Monte Carlo simulation is a method used to iteratively calculate the value of the warrants using simulated stock price paths over the life of the warrants. A summary of the assumptions used to estimate the fair value of the warrants including the anti-dilution feature as of September 30, 2014 and December 31, 2013 is as follows:
		September 30,			December 31,
		2014			2013
	Investor Warrants
	Implied starting stock price	$	0.43		$	0.42
	Volatility		50	%		55	%
	Drift		0.67%-0.89	%		0.75	%
	Exercise price	$	0.75		$	0.75
	Minimum exercise price	$	0.01		$	0.01
	Warrant shares		5,853,530			3,098,736
	Event date	31-Dec-14			30-Sep-14
	Maturity	December 5, 2016 – May 20, 2017			5-Dec-16
	Shares outstanding		31,573,100			34,268,736
		September 30,			December 31,
		2014			2013
	Broker Warrants
	Implied starting stock price	$	0.43		$	0.42
	Volatility		50	%		55	%
	Drift		0.67%-0.75	%		0.75	%
	Exercise price	$	0.5		$	0.5
	Minimum exercise price	$	0.01		$	0.01
	Warrant shares		93,000			77,500
	Event date	31-Dec-14			30-Sep-14
	Maturity	December 5, 2016- February 5, 2017			5-Dec-16
	Shares outstanding		31,573,100			34,268,736
	The fair value of the warrants issued was recorded in accordance with FASB ASC Topic 815-40, Contracts in Entity’s Own Equity. Accordingly, the Company determined that the fair value of the warrants represented a liability because the warrants have an anti-dilution restriction. The fair value of the warrants is recalculated each reporting period with the change in value taken as other income or expense in the Condensed Consolidated Statements of Operations.
	The following table summarizes the activity in Derivative liability- warrants within long term liabilities for the period indicated:
		Nine Months Ended September 30, 2014
		December 31, 2013 Fair Value of Warrant Liability			Fair Value of Warrants Issued						September 30, 2014 Fair Value of Warrant Liability
								Realized Gain on Fair value of Warrant Liabilities
	Investor Warrants	$	294,298		$	262,521		$	(159,977	)	$	396,842
	Broker Warrants		9,364			1,854			(1,008	)		10,210
	Total	$	303,662		$	264,375		$	(160,985	)	$	407,052

10_ACCRUED_EXPENSES_AND_OTHER_

10. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
10. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	'
	Account Description	September 30,		December 31,
		2014		2013
	Advisory and Professional Costs	$	137,654	$	172,051
	Wage Tax Return		28,252		15,177
	Development Costs		31,492		10,063
	Penalty Waiver		14,630		-
	Interest Payable		10,335		8,451
	Holiday Pay Allowance/ Net Salary		8,480		17,648
	Travel and Hotel Costs		-		15,272
	Other Current Liabilities		23,838		18,266
	Total	$	254,681	$	256,928
	Included in Accrued expense and other current liabilities is an accrual of $ 14,630 relates to contractual penalties incurred by the Company payable to participants in the PPO for delays in filing the Registration Statement on Form S-1 with the Securities and Exchange Commission.

11_SHARE_BASED_COMPENSATION_PL

11. SHARE BASED COMPENSATION PLANS	9 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
11. SHARE BASED COMPENSATION PLANS	'
	2013 Stock Incentive Plan
	Under the 2013 Plan, 5 million shares of the Company’s common stock have been reserved for issuance to officers, employees, directors, consultants and advisors to the Company. The stock plan provides for grants of options, stock appreciation rights, performance share awards, restricted stock and restricted stock unit awards (“the Awards”).  Up to 1,666,666 shares may be granted during the first 12 months following the Share Exchange and the remaining 3,333,332 shares may be granted during the first 24 months following the Share Exchange. The vesting period for the Awards under the 2013 Plan is determined by the Board at the date of grant. No awards were granted to employees or non-employees during 2013.
	On July 24, 2014 the Company issued an aggregate of 905,750 restricted stock units (RSUs) to 16 employees, including our four executive officers, and 97,750 shares to non-employee advisors and consultants under the 2013 Equity Incentive Plan. Each restricted stock unit represents the right to receive one share of our restricted common stock upon vesting. Each restricted stock unit issued to employees vests on June 30, 2015. The grant date fair value value of the RSUs was $.44 per share, which was measured based on a weighted average fair value calculation using available observable inputs of recent arm’s length transactions in the Company’s private placement offering and, to a lesser extent, the publicly traded share price.
	The Company recognized share based compensation expense for employee Awards of approximately $80,000 for the three and nine month periods ended September 30, 2014, of which $77,000 and $3,000 was recorded in selling, general and administrative expenses and research and development, respectively.
	Unrecognized compensation expense for unvested employee RSUs at September 30, 2014 was approximately $ 318,000, which is expected to be recognized over the remaining nine month vesting period. As of September 30, 2014, no employees forfeited RSUs awarded in 2014.
	Non-employee Share Based Compensation
	Share- based compensation expense related to restricted stock and restricted stock units (collectively ‘Non-Employee Awards’) granted to non- employees is measured at the fair value of consideration received or the fair value of the equity instruments issued or liabilities incurred, whichever is more reliably measured.  The cost of the share based payments to non- employees that are fully vested and non- forfeitable as at the grant date are remeasured and recognized at that date, unless there is a contractual term for services, in which case such compensation would be amortized over the contractual term. In addition to the shares granted on July 24, 2014 and during the 3 months ended September 30, 2014, the Company issued 90,000 shares of restricted common stock and 30,000 RSUs to non- employee advisors and consultants. Of the 217,750 Awards of restricted stock and restricted stock units issued to non-employees, 117,750 have vested as of September 30, 2014. As of September 30, 2014, no non-employees forfeited restricted stock or RSUs awarded in 2014.
	The Company recognized share based compensation expense for non-employee share based awards of approximately $119,000 and $152,000 for the three and nine month periods ended September 30, 2014. For the three months ended September 30, 2014, share based compensation expenses related to non- employees of approximately $111,000 and $8,000 was recorded in professional expenses and selling, general and administrative expenses, respectively. For the nine months ended September 30, 2014, share based compensation expenses related to non-employees of approximately $140,000 and $12,000 was recorded in professional expenses and selling, general, and administrative expenses, respectively. As of September 30, 2014 and December 31, 2014, the Company has recorded approximately $110,000 and $ 0 in accrued expenses and other liabilities related to these non- employee share arrangements, which are either subject to continued contractual service conditions or have not been settled in common stock of the Company.
	Unrecognized compensation expense for unvested non-employee RSUs at September 30, 2014 was approximately $44,000, which is expected to be recognized over a weighted average of 1.3 years.
	Share Based Compensation
	The following table shows a summary of share based compensation expense included in the consolidated statement of operations for the three and nine month periods ended September 30, 2014 and 2013:
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	Selling, general and administrative	$	85,872	$	-	$	89,722	$	-
	Professional fees		110,982		-		139,455		-
	Research and development costs		2,656	$	-	$	2,656	$	-
	Total	$	199,510		-	$	231,833		-

12_RELATED_PARTY_TRANSACTIONS

12. RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2014
Related Party Transactions	'
12. RELATED PARTY TRANSACTIONS	'
	Management Fees
	For the three and nine months ended September 30, 2014, the Company compensated three members of its management team through management agreements with affiliates of these three members. During the first quarter of 2013, the Company compensated its three officers through management agreements with the affiliates of these officers. Following the Share Exchange on December 6, 2013, these three officers became salaried employees of Symbid Corp. During the three month and nine month periods ended September 30, 2014, total expenses recorded under these agreements were approximately $39,000 and $178,000, respectively. During three and nine month periods ended September 30, 2013, total expenses recorded under these agreements were approximately $39,000 and $43,000, respectively. As of September 30, 2014, and December 31, 2013, balances due under these agreements were approximately $30,533 and $0, respectively, and are included in accounts payable.
	Other
	See Note 7 for related party financing arrangements.

13_COMMITMENTS

13. COMMITMENTS	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
13. COMMITMENTS	'
	As of January 1, 2014, the Company entered into a new rental agreement for its corporate offices in the Netherlands. Rent payments totals $1,700 per month. The rental agreement has a term of two years. The annual commitment under this lease is approximately $20,000.
	As of September 18, 2014, the Company entered into an Advisory Agreement with Capital Markets Group LLC to provide investor & public relations services for a 12 month period for approximately $5,000 per month. The Company has the option to cancel the contract after 5 months.

2_SUMMARY_OF_SIGNIFICANT_ACCOU1

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2014
Significant Accounting Policies	'
Principles of Consolidation	'
	The accompanying condensed consolidated financial statements include the accounts of the Company and its significant subsidiaries on a consolidated basis. The Company also includes subsidiaries over which a direct or indirect legal or effective control exists and for which the Company is deemed to direct the significant activities and has the obligation to absorb the losses or benefits of the entities. Intercompany balances and transactions with other consolidated entities have been eliminated. The condensed consolidated financial statements have been prepared in accordance with U.S. GAAP, and include the Company’s accounts as well as those of Symbid Coöperatie UA (“Symbid Coop”) a certain variable interest entity (“VIE”) for which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated.
Use of Estimates	'
	The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Noncontrolling Interests	'
	The Company presents noncontrolling interests as a component of equity. Changes in a parent’s ownership interest while the parent retains its controlling interest will be accounted for as equity transactions, and upon loss of control, retained ownership interest will be re-measured at fair value, with any gain or loss recognized in earnings. Income and losses attributable to the noncontrolling interest associated with Symbid Coop are presented separately in the Company’s condensed consolidated statement of operations.
Revenue Recognition	'
	The Company generates its revenue from administration and success fees of transactions on the crowd funding platform. Revenue from administration fees is collected and recognized at the moment an investor subscribes on the platform. Revenue from success fees are recognized at the time the crowdfunding proposition is successfully funded and there are no further obligations to the customer. There is no credit risk since the fees are collected directly at the moment that the transaction takes place on the platform. There is no right of return to investors once a crowdfunding proposition has been successfully funded. Other revenue is generated by licensing the platform to third parties. Revenue is accounted for on a monthly basis for the agreed monthly licensed fee. There is limited credit risk. If the monthly license fee is not paid, the Company is entitled to set the platform offline.
Share Based Compensation	'
	ASC Topic 718, Compensation – Stock Compensation, requires that compensation expense for employee stock- based compensation be recognized over the requisite service period based on the fair value of the award on the date of grant.
	The Company accounts for the granting of equity based awards to employees using the fair value method, whereby all awards to employees will be recorded at fair value on the date of grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. The fair value of equity based awards is estimated using the most recent securities offering of the same or similar share classes. Compensation costs for stock- based payments to employees with graded vesting are recognized on a straight line basis.
	Based on guidance in ASC 505, Equity share based payments to non- employees are measured at the fair value of the consideration received or the fair value of the equity instruments issued or liabilities incurred, whichever is more reliably measurable. The fair value of share based payments to non- employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for share based payments with graded vesting are recognized on a straight- line basis. The cost of the share based payments to non- employees that are fully vested and non- forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.
Derivative Liability - Warrants	'
	In connection with the private placement offering (“PPO”) on December 6, 2013, the Company issued warrants to purchase shares of its common stock to investors who purchased units in the PPO (“Investor Warrants”). The Company also issued warrants to purchase shares of its common stock to brokers in connection with the PPO (“Broker Warrants”). Both the Investor and Broker Warrants, at the option of the holder, may be exercised by cash payment of the exercise price to the Company. The warrants may be exercised on a cashless basis in accordance with the warrant agreement commencing one year after the initial closing date of the PPO if no registration statement registering the shares underlying the warrants is then in effect. Further, the exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including stock splits, stock dividends, and future issuances of the Company’s equity securities. As a result, the fair value of these warrants were classified as liabilities under the provisions of FASB ASC Topic 815-40, Contracts in an Entity’s Own Equity, as they are not indexed to the Company’s own stock. The fair value of these warrants was estimated using a Monte Carlo simulation. The Company updates its estimate of the fair value of the warrant liabilities in each reporting period as new information becomes available and any gains or losses resulting from the changes in fair value from period to period are included as other income or expense. The Company thus uses model-derived valuations where inputs are observable in active markets to determine the fair value and accordingly classify such warrants in Level 3 per ASC 820, Fair Value Measurements.
Fair Value of Financial Instruments	'
	The accounting standard for fair value establishes a framework for measuring fair value and enhances fair value measurement disclosure. Under the provisions of the pronouncement, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.
	GAAP establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is described below:
	Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
	Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
	Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
	The Company’s current financial assets and liabilities approximate fair value due to their short term nature and include cash accounts. The Company’s borrowings approximate fair value as the rates of interest are similar to what they would receive from other financial institutions. Refer to Note 9 on derivative liability- warrants, which have been classified as Level 3 instruments.
Concentrations of Credit Risk	'
	Cash Held in Banks
	The Company has cash balances at financial institutions located in the Netherlands. Balances at financial institutions in the Netherlands may, from time to time, exceed insured limits. Currently the insured limit amounts to approximately $127,000.
	Accounts Receivable
	Customer accounts typically are collected within a short period of time, and based on its assessment of current conditions and its experience collecting such receivables, management believes it has no significant risk related to its concentration within its accounts receivable.
Foreign Currency Translation	'
	The Company uses the United States dollar (“U.S. dollars” or “USD”) for financial reporting purposes.  The Company's subsidiaries maintain their books and records in their functional currency, the Euro (“EUR”), the currency of the Netherlands.
	In general, for consolidation purposes, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of operations and cash flows are translated at average exchange rates during the reporting period.  As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet.  Equity accounts are translated at historical rates.  Adjustments resulting from the translation of the financial statements are recorded as accumulated other comprehensive income, or loss.
Property and Equipment	'
	Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization is charged to operations using the straight-line method over the estimated useful lives of 5 years. Property and equipment consists mainly of computers.
	Expenditures for maintenance and repairs are charged to operations as incurred. Expenditures for betterments and major renewals are capitalized. The cost of assets sold or retired and the related amounts of accumulated depreciation are eliminated from the accounts in the period of disposal, and any resulting gains or losses are included in operations.
Income Taxes	'
	Income taxes have been determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes result from differences between the financial statement and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. The assessment of whether or not a valuation allowance is required often requires significant judgment.
Net Loss Per Common Share	'
	Basic and diluted net loss per share is presented in conformity with ASC Topic 260, Earnings per Share, for all periods presented. In accordance with this guidance, basic and diluted net loss per share was determined by dividing net loss applicable to common stockholders by the weighted- average common shares outstanding during the period. In a period where there is a net loss position, diluted weighted average shares are the same as basic weighted average shares. Shares used in the diluted net loss per common share calculation exclude potentially dilutive share equivalents, as the effect would be antidilutive.
Risks and Uncertainties	'
	The Company’s operations are subject to a number of risks, including but not limited to, changes in the general economy, demand for the Company’s platform, the success of its customers, research and development results, uncertainties surrounding crowd funding rules and regulations, and the ability to attract new funding.
Accounts Receivable	'
	Accounts receivable are carried at the amount billed to a customer, net of the allowance for doubtful accounts, which is an estimate for credit losses based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received. The Company reviews the collectability of accounts receivable based on an assessment of historical experience, current economic conditions, and other collection indicators. At September 30, 2014 and December 31, 2013, the Company has recorded an allowance for doubtful accounts for $8,436 and $10,718, respectively.
Comprehensive Loss	'
	Comprehensive loss refers to revenues, expenses, gains and losses that under U.S. GAAP are included in comprehensive loss but are excluded from net loss as these amounts are recorded directly as an adjustment to stockholders’ equity. The Company’s other comprehensive loss is comprised of foreign currency translation adjustments.
Cost Method Investments	'
	Direct and or indirect investments in business entities in which the Company does not have a controlling financial interest and has no ability to exercise significant influence over operating and financial policies (generally 0-20 percent ownership) are accounted for by the cost method.
Equity Method Investments	'
	Direct and/or indirect investments in business entities in which Symbid Corp. does not have a controlling financial interest, but has the ability to exercise significant influence or operating and financial policies (generally 20-50 percent ownership) are accounted for by the equity method.
Intangible Assets with Definite Lives	'
	An intangible asset arose as the result of the acquisition of the FAC B.V., a limited liability entity incorporated in the Netherlands, resulting in the acquisition of a perpetual, worldwide, exclusive license to a software library of infrastructure technology. The Company amortizes the costs of the acquired intangible asset using the straight- line method over the estimated useful life of 7 years.
	The carrying value of the intangible asset with a definite live is reviewed on a regular basis for the existence of facts or circumstances that the intangible asset may be impaired. An asset is considered impaired when the undiscounted future cash flows expected to result from its planned use are less than the carrying value. If the carrying value of an asset is deemed not recoverable, it is adjusted downward to its estimated fair value.
Recent Accounting Pronouncements	'
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, "Revenue from Contracts with Customers: (Topic 606)." This ASU affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605, "Revenue Recognition," and most industry-specific guidance. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance also includes a cohesive set of disclosure requirements that will provide users of financial statements with comprehensive information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from a reporting organization’s contracts with customers. The amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated condensed financial statements.

3_VARIABLE_INTEREST_ENTITY_SYM1

3. VARIABLE INTEREST ENTITY- SYMBID COOP (Tables)	9 Months Ended
	Sep. 30, 2014
Notes to Financial Statements	'
Schedule of assets and liabilities of Symbid Coop	'
		30-Sep-14		31-Dec-13
	Current assets	$	104,552	$	53,414
	Current liabilities	$	187,463	$	113,137

7_NOTES_PAYABLE_Tables

7. NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Notes Payable	'
		30-Sep-14			31-Dec-13
	Working capital facility	$	153,484		$	187,371
	Subordinated loan – related party		84,926			92,259
	Total notes payable	$	238,410			279,630
	Less - Current Maturities		-132,895	)		(41,657	)
	Notes payable, less current maturities		105,515		$	237,973
Aggregate Maturity Schedule of Borrowings	'
	THE TWELVE MONTHS ENDING September 30,
	2015	$	132,894
	2016		38,375
	2017		38,375
	2018		28,766
		$	238,410

8_CAPITAL_STOCK_Tables

8. CAPITAL STOCK (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Schedule private placement offering	'
	Gross proceeds from the PPO	$	2,926,760
	Issuance costs		(68,000	)
	Proceeds allocated to warranty liability		(570,268	)
	Proceeds allocated to common stock	$	2,288,492
Non-controlling Interests	'
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
	Symbid Coop- 100%	$	(14,631	)	$	-2,840		$	(29,652	)	$	(9,455	)
	Gambitious Coop- 37%		-			(5,231	)		-602			(17,946	)
	Total	$	(14,631	)	$	(8,071	)	$	(30,254	)	$	(27,401	)

9_DERIVATIVE_LIABILITY_WARRANT1

9. DERIVATIVE LIABILITY - WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Warrants	'
		September 30,			December 31,
		2014			2013
	Investor Warrants
	Implied starting stock price	$	0.43		$	0.42
	Volatility		50	%		55	%
	Drift		0.67%-0.89	%		0.75	%
	Exercise price	$	0.75		$	0.75
	Minimum exercise price	$	0.01		$	0.01
	Warrant shares		5,853,530			3,098,736
	Event date	31-Dec-14			30-Sep-14
	Maturity	December 5, 2016 – May 20, 2017			5-Dec-16
	Shares outstanding		31,573,100			34,268,736
		September 30,			December 31,
		2014			2013
	Broker Warrants
	Implied starting stock price	$	0.43		$	0.42
	Volatility		50	%		55	%
	Drift		0.67%-0.75	%		0.75	%
	Exercise price	$	0.5		$	0.5
	Minimum exercise price	$	0.01		$	0.01
	Warrant shares		93,000			77,500
	Event date	31-Dec-14			30-Sep-14
	Maturity	December 5, 2016- February 5, 2017			5-Dec-16
	Shares outstanding		31,573,100			34,268,736
Warrant Rollforward	'
		Nine Months Ended September 30, 2014
		December 31, 2013 Fair Value of Warrant Liability			Fair Value of Warrants Issued						September 30, 2014 Fair Value of Warrant Liability
								Realized Gain on Fair value of Warrant Liabilities
	Investor Warrants	$	294,298		$	262,521		$	(159,977	)	$	396,842
	Broker Warrants		9,364			1,854			(1,008	)		10,210
	Total	$	303,662		$	264,375		$	(160,985	)	$	407,052

10_ACCRUED_EXPENSES_AND_OTHER_1

10. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES	'
	Account Description	September 30,		December 31,
		2014		2013
	Advisory and Professional Costs	$	137,654	$	172,051
	Wage Tax Return		28,252		15,177
	Development Costs		31,492		10,063
	Penalty Waiver		14,630		-
	Interest Payable		10,335		8,451
	Holiday Pay Allowance/ Net Salary		8,480		17,648
	Travel and Hotel Costs		-		15,272
	Other Current Liabilities		23,838		18,266
	Total	$	254,681	$	256,928

11_SHARE_BASED_COMPENSATION_PL1

11. SHARE BASED COMPENSATION PLANS (Tables)	3 Months Ended
	Sep. 30, 2014
Share Based Compensation Plans Tables	'
Schedule of share based compensation plans	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	Selling, general and administrative	$	85,872	$	-	$	89,722	$	-
	Professional fees		110,982		-		139,455		-
	Research and development costs		2,656	$	-	$	2,656	$	-
	Total	$	199,510		-	$	231,833		-

3_VARIABLE_INTEREST_ENTITY_SYM2

3. VARIABLE INTEREST ENTITY- SYMBID COOP (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Variable Interest Entity- Symbid Coop Details	'	'
Current assets	$104,552	$53,414
Current liabilities	$187,463	$113,137

7_NOTES_PAYABLE_Details

7. NOTES PAYABLE (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Notes Payable Details	'	'
Working capital facility - term loan	$153,484	$187,371
Subordinated loan b related party	84,926	92,259
Total	238,410	279,630
Less - Current Maturities	-132,895	-41,657
Notes payable, less current maturities	$105,515	$237,973

5_NOTES_PAYABLE_Details_1

5. NOTES PAYABLE (Details 1) (USD $)	Sep. 30, 2014
Notes Payable Details	'
2015	$132,894
2016	38,375
2017	38,375
2018	28,766
Total	$238,410

6_CAPITAL_STOCK_Details

6. CAPITAL STOCK (Details) (USD $)	Sep. 30, 2014
Capital Stock Details	'
Gross proceeds from the PPO	$2,926,760
Issuance costs	-68,000
Proceeds allocated to warrant liability	-570,268
Proceeds allocated to common stock	$2,288,492

6_CAPITAL_STOCK_Details_1

6. CAPITAL STOCK (Details 1) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Noncontrolling Interest [Abstract]	'	'	'	'
Symbid Coop - 100%	($14,631)	($2,840)	($29,652)	($9,455)
Gambitious Coop - 37%	0	-5,231	-602	-17,946
Total net loss attributable to NCI	($14,631)	($8,071)	($30,254)	($27,401)

7_DERIVATIVE_LIABILITY_WARRANT

7. DERIVATIVE LIABILITY - WARRANTS (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Investor Warrants	'	'
Event date	'2014-12-31	'2014-09-30
Maturity	'December 5, 2016 B May 20, 2017	'2016-12-05
Broker Warrants	'	'
Event date	'2014-12-31	'2014-09-30
Maturity	'December 5, 2016- February 5, 2017	'2016-12-05
Investor Warrants	'	'
Implied starting stock price	0.43	0.42
Volatility	5000.00%	55.00%
Drift	'	0.75%
Drift, minimum	0.67%	'
Drift, maximum	0.89%	'
Exercise price	0.75	0.75
Minimum exercise price	0.01	0.01
Warrant shares	5,853,530	3,098,736
Shares outstanding	31,573,100	34,268,736
Broker Warrants	'	'
Implied starting stock price	0.43	0.42
Volatility	50.00%	55.00%
Drift	'	0.75%
Drift, minimum	0.67%	'
Drift, maximum	0.75%	'
Exercise price	0.5	0.5
Minimum exercise price	0.01	0.01
Warrant shares	93,000	77,500
Shares outstanding	31,573,100	34,268,736

7_DERIVATIVE_LIABILITY_WARRANT1

7. DERIVATIVE LIABILITY - WARRANTS (Details 1) (USD $)	9 Months Ended
	Sep. 30, 2014
December 31, 2013 Fair Value of Warrant Liability	$303,662
Fair Value of Warrants Issued	264,375
Realized Gain on change in fair value of Warrant Liabilities	-160,985
September 30, 2014 Fair Value of Warrant Liability	407,052
Investor Warrants	'
December 31, 2013 Fair Value of Warrant Liability	294,298
Fair Value of Warrants Issued	262,521
Realized Gain on change in fair value of Warrant Liabilities	-159,977
September 30, 2014 Fair Value of Warrant Liability	396,842
Broker Warrants	'
December 31, 2013 Fair Value of Warrant Liability	9,364
Fair Value of Warrants Issued	1,854
Realized Gain on change in fair value of Warrant Liabilities	-1,008
September 30, 2014 Fair Value of Warrant Liability	$10,210

10_ACCRUED_EXPENSES_AND_OTHER_2

10. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Accrued Expenses And Other Current Liabilities Details	'	'
Advisory and professional costs	$137,654	$172,051
Wage tax' return	28,252	15,177
Development costs	31,492	10,063
Penalty waiver	14,630	0
Interest payable	10,335	8,451
Holiday pay allowance/Net salary	8,480	17,648
Travel and hotel costs	0	15,272
Other current liabilities	23,838	18,266
Accrued expenses and other current liabilities	$254,681	$256,928

11_SHARE_BASED_COMPENSATION_PL2

11. SHARE BASED COMPENSATION PLANS (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share Based Compensation Plans Details	'	'	'	'
Selling, general and administrative	$85,872	$0	$89,722	$0
Professional fees	110,982	0	139,455	0
Research and development costs	2,656	0	2,656	0
Total	$199,510	$0	$231,833	$0